Products & Pipeline

One platform. A growing pipeline of therapeutics.

From our flagship product BIO-PLY™ to a growing pipeline of innovative biologics, every Qentoros therapy is guided by rigorous science, manufactured to uncompromising quality standards, and developed through meaningful clinical results for real-world impact.

Available Now

✓ In clinical useEquineIntra-synovial

BIO-PLY™

The first-in-class, triple-action peptide biologic developed specifically for equine septic joints.

Triple action

Antimicrobial, anti-inflammatory, and pro-healing in one treatment.

Off the shelf

One vial, no prep — ready to use in the clinic.

FDA pathway

Advancing through FDA-CVM regulatory review.

Vials of BIO-PLY, a platelet-derived peptide biologic

The Q-Biologics™ Platform

Building the future of peptide biologics.

BIO-PLY™ is the first product to emerge from our platform. Additional peptide biologics are advancing through development to address infectious, inflammatory, and degenerative diseases in veterinary medicine. While we can’t yet share every detail of these programs, we’re excited to provide a preview of what’s ahead.

BIO-PLY™
Platelet-derived peptide biologic
Horse
Septic synovial infections
FDA pathway*
Horse
Endometritis
Clinical trials
Dog
Otitis externa
Clinical trials
Dog
Implant-associated infections
Clinical trials
Horse
Keratitis
Discovery
NAP-X™
Neutrophil-derived peptide biologic
Horse
Respiratory infections
Preclinical
Future peptide biologics
Novel host-defense peptide platforms
Multiple species
Programs in evaluation
Discovery
Discovery
Early research and proof-of-concept
Preclinical
Laboratory and animal studies
Clinical trials
Used in veterinary clinical trials
FDA pathway*
Advancing through the FDA approval process
FDA approved
Commercially available veterinary product

*BIO-PLY™ is participating in the FDA Center for Veterinary Medicine (FDA-CVM) Animal Cell, Tissue, and Gene Therapy (ACTP) Veterinary Innovation Program. Participation reflects active collaboration with the FDA-CVM to support product development and regulatory review, and does not constitute FDA approval.

Development stages and timing are indicative and subject to change. Contact us for the current status of any program.

Stay in the loop

Sign up for our newsletter.

Be the first to hear about new products, clinical trials, events we're attending, company milestones, and more — delivered straight to your inbox.

Prefer social? Follow us on LinkedIn — we announce new products, clinical trials, events, and milestones there too.

Get started

Interested in BIO-PLY™?

Register to receive more information about using BIO-PLY™ in your clinic.

Register

Everything else

Get in touch

Trials, partnerships, investment, or press, we'd love to hear from you.

Contact us